SB 258741 hydrochloride 是一种特异性的5-HT7受体拮抗剂,可用于精神分裂症的研究。
生物活性 | SB 258741 hydrochloride is a specific5-HT7receptorantagonist and can be used for the research of schizophrenia[1]. |
IC50& Target | |
体外研究 (In Vitro) | SB-258741 behaves as a partial inverse agonist, the antagonist potency (apparent pKB) is 8.47[2].
|
体内研究 (In Vivo) | SB 258741 (0-9.1 mg/kg; s.c.; once or daily for 3 days) shows antipsychotic effects in rats[1].
Animal Model: | Male Wistar rats, 250 –300 g in the phencyclidine (PCP)-disrupted prepulse inhibition (PPI) and PCP-disrupted social interaction (SIT) paradigm, 200 – 250 g in the catalepsy, motility, and D-amphetamine hyperactivity paradigms[1] | Dosage: | 0.56, 2.3, 4.6 and 9.1 mg/kg | Administration: | Subcutaneous injection, once or daily for 3 days (social interaction test) | Result: | Reversed hyperactivity induced by D-amphet-amine over 0.56 mg/kg, and reduced motility at 4.6 and 9.1 mg/kg. Did not reverse D-Amphetamine-disrupted PPI, but enhanced PCP-disrupted PPI. Reduced PCP (2 mg/kg)-induced hyperactivity. |
|
分子量 | |
Formula | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |